Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22.
NEW ORLEANS — A cholesterol-lowering injection that’s been on the market for nearly a decade has now shown its power to cut cardiovascular events in people considered at high risk but who haven’t yet suffered a heart attack or stroke.
About Medical Newswire™ aggregates, publishes and distributes news about the medical industry. In association with EmailWire, Medical Newswire™ provides press release distribution services in the medical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us at these messaging apps:
Mobile/WhatsApp: +1832-716-2363
Skype: groupwebmedia
Telegram: @groupwebmedia
Medical Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC